Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies

Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

(2013) A. D. Althouse et al.   DIABETES CARE

Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness

(2012) Tim Crul et al.   CURRENT PHARMACEUTICAL DESIGN

Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model

(2012) A. Cittadini et al.   DIABETES

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

(2012) A. Neumann et al.   DIABETOLOGIA

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

(2011) Michael Elashoff et al.   GASTROENTEROLOGY

Effects of different small HSPB members on contractile dysfunction and structural changes in a Drosophila melanogaster model for Atrial Fibrillation

(2011) Deli Zhang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical Trial

(2009) B. Literáti-Nagy et al.   HORMONE AND METABOLIC RESEARCH

Inflammation, heat shock proteins, and type 2 diabetes

(2008) Philip L. Hooper et al.   CELL STRESS & CHAPERONES

HSP72 protects against obesity-induced insulin resistance

(2008) J. Chung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study

(2007) E. Mannucci et al.   DIABETES OBESITY & METABOLISM